Sulfoamino derivatives of chondroitin sulfates, of dermatan...

C - Chemistry – Metallurgy – 08 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/199, 260/219

C08B 37/08 (2006.01) A61K 31/715 (2006.01)

Patent

CA 1307525

-1- SULFOAMINO DERIVATIVES OF CHONDROITIN SULFATES, OF DERMATAN SULFATE AND OF HYALURONIC ACID AND THEIR PHARMACOLOGICAL PROPERTIES. ABSTRACT Novel derivatives are disclosed as obtained from chondroitin sulfate, dermatan sulfate and hyaluronic acid, having a molar ratio between sulfate groups and carboxylic groups like that of heparin and furthermore characterized by possessing, as the heparin, the sulfoamino group at the carbon atom at the 6 position of hexosamine. The novel compounds show a very remarkable clearing activity in comparison with the starting mucopolysaccharides, this activity being similar and for some derivatives comparable with that of heparin. Moreover, differently from what normally happens upon sulfating the sulfomucopolysaccharides, the anticoagulating activity of the novel compounds is negligible or anyhow very reduced. The compounds of the present invention find use in the therapy of arteriosclerosis.

598507

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sulfoamino derivatives of chondroitin sulfates, of dermatan... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfoamino derivatives of chondroitin sulfates, of dermatan..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfoamino derivatives of chondroitin sulfates, of dermatan... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1179574

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.